-
All seven global companies’ near-term targets aligned to the 1.5°C pathway
Endorsement of commitments and action by health systems partners
-
SOURCE: Stanley Black Decker DESCRIPTION:WASHINGTON, D.C. (December 15, 2020) — Stanley Black Decker is the latest organization to sign on to the Renewable Thermal Collaborative’s (RTC) Buyers’ Statement, furthering their commitment to renewable thermal energy use and continued efforts to lower overall greenhouse gas emissions. By becoming a signatory, Stanley Black Decker will be joining a coalition of 21 other global organizations, including Cargill, Procter Gamble, AstraZeneca, Novo Nordisk, a
-
Reserve your seat at our 2020 webinar and hear from Novo Nordisk, Schneider Electric and WWF on their net-zero journey, Thu, Feb 20, 2020 10:00 AM - 11:00 AM EST
-
Novo Nordisk and Discovery Education—the global leader in standards-aligned digital curriculum resources, engaging content, and professional learning for K-12 classrooms—announced the winners of the annual Super Health, Super You Community Challenge.
-
Novo Nordisk, a global healthcare company, and Discovery Education, the leading provider of digital content and professional development for K-12 classrooms, today announced the Super Health, Super You Community Health Challenge winners in celebration of thriving, healthy and active school communities across the United States.
-
Novo Nordisk, a global health care leader in diabetes care and Discovery Education, the leading provider of digital content and professional development for K-12 classrooms, today announced the 2017 Super Health, Super You Community Health Challenge winners in celebration of thriving, healthy and active school communities across the United States.
-
Like many other countries in the region, Algeria is facing the growing health challenge of non-communicable diseases (NCDs). In fact, more than three-quarters of deaths in Algeria today are related to NCDs, including diabetes.
-
Today, an extensive awareness campaign was launched in Lagos, Nigeria, to promote early diagnosis of diabetes through screening, especially among low income populations.
-
Novo Nordisk remains at the top of the pharmaceutical sector on the 2016 Dow Jones Sustainability Indices (DJSI) with a score of 83 out of a possible 100. The company’s score is an improvement of two points from 2015, six points behind Roche, the 2016 industry leader.
-
-
Located on the hillside where Galileo Galilei was watching the stars, the Italian Barometer Diabetes Observatory Foundation breaks new ground in chronic disease management through a unique partnership model.
-
In the pharmaceutical industry, working with the end customer is easier said than done. Nevertheless, Research and Development (R&D) teams across Novo Nordisk have now started partnering with patient leaders through a specialised unit within Novo Nordisk R&D.
-
It’s 43 °C (104 °F) and Ulrik Uldall Nielsen has just travelled 70 kilometres to Thies from Senegal’s capital Dakar to visit one of the clinics expected to be enrolled in Novo Nordisk’s Changing Diabetes® in Children (CDiC) programme.
-
The international community committed in 2015 to the most ambitious global agenda to date – the Sustainable Development Agenda – aiming to end poverty and ensure prosperity, peace and a sustainable planet for all by 2030.
-
The opportunities to create positive change are all around us and stronger alignment of purpose is bringing us closer together. As a pharmaceutical company, we spend and invest significant resources every day on improving health for millions of people living with diabetes and other serious chronic diseases. But the cause of the diabetes epidemic, and the solutions required to make a change are multidimensional.
-
-
With many years of personal and professional experience in the diabetes field, patient advocate Kelly Close and her colleague Emily Regier from Close Concerns offer their perspective on Cities Changing Diabetes1.
-
In 1886 a large gold reef was discovered on a remote African farm setting off a major gold rush that led to the establishment of Johannesburg. As the news spread, the population of the city exploded with people hoping to find the riches and Johannesburg quickly became the largest city in South Africa.1 In fact, the Zulu name for Johannesburg is Egoli which means City of Gold.
-
Preparing meals at home can be challenging for the millions living in cities. Everything from long work days to cheap and convenient fast food options makes choosing to cook fresh and balanced meals difficult. But these dietary choices are also contributing to the rise of type 2 diabetes in cities around the world.
-
Why might cities be the best place for social change to happen? Who better to answer this than Mark Watts, Executive Director of C40 Cities Climate Leadership Group (C40). C40 connects more than 80 of the world’s largest cities, where change can have impact and scalability. We talked to Mark about the connection between climate change and type 2 diabetes.
-
Increased urbanisation has fuelled the consumption of processed food and beverage, rich in sugar, fat and sodium.[3] Simultaneously, city dwellers have experienced a decrease in the time available for food preparation and physical exercise, which drives the rapid increase in levels of overweight, obesity and related diseases in Mexico City.
-
Cities influence how we live, travel and eat, all of which have an impact on our health. Novo Nordisk’s latest issue of TBL Quarterly takes you to the city streets to show the challenges and opportunities to improve the health of urbanites living with type 2 diabetes.
-
Today, Novo Nordisk published a new issue of the company’s sustainability magazine, TBL Quarterly. The latest instalment – The Urban Issue – presents recent research on urban health and some of the actions being taken to prevent chronic disease and improve treatment.
-
Today Novo Nordisk published its 2015 Annual Report detailing the company’s year-end performance. The report highlights the company’s progression towards long-term targets taking an integrated approach that accounts for financial, social and environmental performance. This is the company’s 12th integrated report.
-
-
Today, Novo Nordisk received the top position in the pharmaceuticals industry group on the 2016 Global 100 Most Sustainable Corporations in the World (Global 100) Index. Overall, the company ranked 19, a decrease of six places from 2015. The Index highlights the global companies that are most proactive in managing their environmental and social performance as well as corporate governance issues.
-
The form and composition of cities – their size, density, diversity and complexity – provide tremendous opportunity for understanding the drivers behind type 2 diabetes, thus making cities a focal point for developing interventions that can break the rising curve of diabetes. Getting to these solutions requires an understanding of how societal factors and individual behaviour associated with urban living influence an individual’s risk of developing type 2 diabetes.
-
On December 9th, the Novo Nordisk team and bloggers, Kelly Close and Phyllisa Deroze, joined us to discuss how we talk about diabetes. As the chat kicked off, our panelists and audience dove right into the conversation – sharing their own stories and experiences and pointing out commonalities.
-
Throughout the year, Novo Nordisk shared stories and videos telling the actions and initiatives that demonstrate the company’s commitment to financial, environmental and social responsibility. Here is a recap of the five stores that received the most clicks!
-
Global diabetes company, Novo Nordisk, produces nearly half of the world’s insulin at its production sites across the world. A new commitment to renewable electricity ensures meeting the needs for the company’s products is done in a sustainable way.
-
Today, Novo Nordisk published a new issue of the company’s sustainability magazine, TBL Quarterly. The new issue – Patient focus: A snapshot of why we are in business – shows the value of dialogue and including the voice of people with diabetes and other chronic conditions in business decisions.
-
Did you know there is more to the words “I have diabetes” than you might think? Even though diabetes is a common condition, a lot of myths and misunderstandings still exist, and many are not aware of the difference between type 1 and type 2 diabetes. For friends, family members and coworkers, knowing how to talk about diabetes can prove difficult - also for Novo Nordisk - which is why we want to hear what you have to say.
-
-
The Cities Changing Diabetes Summit will provide a unique occasion for global and local partners in the programme to connect across cities and unite against the challenge of #urbandiabetes.
-
When talking about global development, we tend to think of developing world challenges such as poverty reduction, HIV/AIDS and access to clean water. However, with the adoption of the new Sustainable Development Goals (SDGs), sustainable development has become a universal concern that must be addressed in both low- and high income countries. In the US, the city of Houston illustrates the health challenges of modern urban life.
-
-
Today, Novo Nordisk was recognised as a Nordic leader for the quality of climate change related information that it has disclosed to investors and the global marketplace through CDP (Carbon Disclosure Project).
-
The world adopted what will become the new global job description last week. The list of the 17 Sustainable Development Goals (SDGs) will impact the way we do policy and business.
-
Here is a statistic that may not shock as many people as it should.
-
For the second straight year, the global research company Frost & Sullivan has named Novo Nordisk Indonesia the Diabetes CSR Company of the Year. The acknowledgement recognises the company’s commitment and collaboration to improve care for the six million people with diabetes living in major cities across Indonesia.
-
As the UN General Assembly gets underway, Charlotte Ersbøll, corporate vice president in Novo Nordisk, reflects on the post-2015 agenda and why health must remain at the heart of sustainable development.
-
Next week, world leaders will launch a new round of goals, targets and indicators to pick up where the Millennium Development Goals left off. In the new issue of Novo Nordisk’s sustainability magazine – TBL Quarterly – the company shows how improving the prevention and treatment of type 2 diabetes plays a key role in achieving many of the 17 new Sustainable Development Goals (SDGs).
-
Novo Nordisk stays in top of the pharmaceutical sector on the 2015 Dow Jones Sustainability World Index with a score of 81 out of a possible 100. The company’s overall score falls 3 points from 2014 and is 7 points behind Roche, the 2015 industry leader.
-
-
-
-
-
-
-